ListarCIENCIAS EXPERIMENTALES por tema "Angiogenesis"
Mostrando ítems 1-4 de 4
-
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma. García Romero, Noemí; Palacín Aliana, I.; Madurga Lacalle, Rodrigo; Carrión Navarro, Josefa; Esteban Rubio, S.; Jiménez, B.; Collazo, A.; Pérez Rodríguez, F.; Ortiz de Mendivil, A.; Fernández Carballal, C.; García Duque, s.; Diamantopoulos-Fernández, J.; Belda Iniesta, C.; Prat Acín, R.; Sánchez Gómez, P.; Calvo, E.; Ayuso Sacido, Ángel (BMC Medicine, 2020)
-
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies. Albiñana, Virginia; Gallardo-Vara, Eunate; Casado Vela, Juan; Recio Poveda, Lucía; Botella, Luisa María; Cuesta, Ángel (Journal of Clinical Medicine, 2022)
-
The low affinity A2B adenosine receptor enhances migratory and invasive capacity in vitro and angiogenesis in vivo of glioblastoma stem-like cells. Erices, José I.; Niechi, Ignacio; Uribe-Ojeda, Atenea; Toro, Mª Ángeles; García Romero, Noemí; Carrión Navarro, Josefa; Monago Sánchez, Álvaro; Ayuso Sacido, Ángel; San Martín, Rody; Quezada-Monras, Claudia (Frontiers in Oncology, 2022)
-
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases. Cuesta, Angel M.; Gallardo-Vara, Eunate; Casado Vela, Juan; Recio-Poveda, Lucía; Botella, Luisa-María; Albiñana, Virginia (International Journal of Molecular Sciences, 2022)